nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0053	0.248	CbGbCtD
Brinzolamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00401	0.188	CbGbCtD
Brinzolamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.00344	0.161	CbGbCtD
Brinzolamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0034	0.159	CbGbCtD
Brinzolamide—CYP3A4—Prednisone—ankylosing spondylitis	0.00321	0.15	CbGbCtD
Brinzolamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.002	0.0937	CbGbCtD
Brinzolamide—Erythema—Methylprednisolone—ankylosing spondylitis	0.00192	0.00196	CcSEcCtD
Brinzolamide—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00192	0.00196	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—ankylosing spondylitis	0.00191	0.00195	CcSEcCtD
Brinzolamide—Malaise—Prednisolone—ankylosing spondylitis	0.00189	0.00193	CcSEcCtD
Brinzolamide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00188	0.00192	CcSEcCtD
Brinzolamide—Vertigo—Prednisolone—ankylosing spondylitis	0.00188	0.00192	CcSEcCtD
Brinzolamide—Eye disorder—Betamethasone—ankylosing spondylitis	0.00187	0.00191	CcSEcCtD
Brinzolamide—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00187	0.00191	CcSEcCtD
Brinzolamide—Back pain—Triamcinolone—ankylosing spondylitis	0.00186	0.0019	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—ankylosing spondylitis	0.00182	0.00186	CcSEcCtD
Brinzolamide—Angiopathy—Betamethasone—ankylosing spondylitis	0.00182	0.00186	CcSEcCtD
Brinzolamide—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00182	0.00186	CcSEcCtD
Brinzolamide—Hypertension—Prednisolone—ankylosing spondylitis	0.00181	0.00184	CcSEcCtD
Brinzolamide—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00179	0.00183	CcSEcCtD
Brinzolamide—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00179	0.00183	CcSEcCtD
Brinzolamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00178	0.00182	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00178	0.00182	CcSEcCtD
Brinzolamide—Bradycardia—Prednisone—ankylosing spondylitis	0.00178	0.00182	CcSEcCtD
Brinzolamide—Alopecia—Dexamethasone—ankylosing spondylitis	0.00177	0.00181	CcSEcCtD
Brinzolamide—Alopecia—Betamethasone—ankylosing spondylitis	0.00177	0.00181	CcSEcCtD
Brinzolamide—Discomfort—Prednisolone—ankylosing spondylitis	0.00176	0.0018	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00175	0.00179	CcSEcCtD
Brinzolamide—Erythema—Dexamethasone—ankylosing spondylitis	0.00174	0.00178	CcSEcCtD
Brinzolamide—Erythema—Betamethasone—ankylosing spondylitis	0.00174	0.00178	CcSEcCtD
Brinzolamide—Malaise—Triamcinolone—ankylosing spondylitis	0.00173	0.00177	CcSEcCtD
Brinzolamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00173	0.00177	CcSEcCtD
Brinzolamide—Vertigo—Triamcinolone—ankylosing spondylitis	0.00173	0.00177	CcSEcCtD
Brinzolamide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00172	0.00176	CcSEcCtD
Brinzolamide—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00172	0.00175	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00168	0.00172	CcSEcCtD
Brinzolamide—Cough—Triamcinolone—ankylosing spondylitis	0.00168	0.00171	CcSEcCtD
Brinzolamide—Tachycardia—Prednisolone—ankylosing spondylitis	0.00167	0.0017	CcSEcCtD
Brinzolamide—Hypertension—Triamcinolone—ankylosing spondylitis	0.00166	0.0017	CcSEcCtD
Brinzolamide—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00166	0.00169	CcSEcCtD
Brinzolamide—Myalgia—Triamcinolone—ankylosing spondylitis	0.00164	0.00167	CcSEcCtD
Brinzolamide—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00163	0.00167	CcSEcCtD
Brinzolamide—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00163	0.00167	CcSEcCtD
Brinzolamide—Eye disorder—Prednisone—ankylosing spondylitis	0.00163	0.00167	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00162	0.00166	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—ankylosing spondylitis	0.00162	0.00166	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00162	0.00166	CcSEcCtD
Brinzolamide—Depression—Methotrexate—ankylosing spondylitis	0.00162	0.00166	CcSEcCtD
Brinzolamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00162	0.00165	CcSEcCtD
Brinzolamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00162	0.00165	CcSEcCtD
Brinzolamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.00162	0.00165	CcSEcCtD
Brinzolamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00161	0.00165	CcSEcCtD
Brinzolamide—Dry mouth—Triamcinolone—ankylosing spondylitis	0.0016	0.00164	CcSEcCtD
Brinzolamide—Angiopathy—Prednisone—ankylosing spondylitis	0.00158	0.00162	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00158	0.00161	CcSEcCtD
Brinzolamide—Immune system disorder—Prednisone—ankylosing spondylitis	0.00158	0.00161	CcSEcCtD
Brinzolamide—Malaise—Betamethasone—ankylosing spondylitis	0.00157	0.00161	CcSEcCtD
Brinzolamide—Malaise—Dexamethasone—ankylosing spondylitis	0.00157	0.00161	CcSEcCtD
Brinzolamide—Vertigo—Betamethasone—ankylosing spondylitis	0.00157	0.0016	CcSEcCtD
Brinzolamide—Vertigo—Dexamethasone—ankylosing spondylitis	0.00157	0.0016	CcSEcCtD
Brinzolamide—Arrhythmia—Prednisone—ankylosing spondylitis	0.00156	0.00159	CcSEcCtD
Brinzolamide—Infection—Triamcinolone—ankylosing spondylitis	0.00156	0.00159	CcSEcCtD
Brinzolamide—Infection—Methylprednisolone—ankylosing spondylitis	0.00156	0.00159	CcSEcCtD
Brinzolamide—Insomnia—Prednisolone—ankylosing spondylitis	0.00154	0.00158	CcSEcCtD
Brinzolamide—Alopecia—Prednisone—ankylosing spondylitis	0.00154	0.00158	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00154	0.00157	CcSEcCtD
Brinzolamide—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00154	0.00157	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—ankylosing spondylitis	0.00153	0.00157	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00153	0.00157	CcSEcCtD
Brinzolamide—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00153	0.00157	CcSEcCtD
Brinzolamide—Mental disorder—Prednisone—ankylosing spondylitis	0.00153	0.00156	CcSEcCtD
Brinzolamide—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00153	0.00156	CcSEcCtD
Brinzolamide—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00152	0.00155	CcSEcCtD
Brinzolamide—Malnutrition—Prednisone—ankylosing spondylitis	0.00152	0.00155	CcSEcCtD
Brinzolamide—Erythema—Prednisone—ankylosing spondylitis	0.00152	0.00155	CcSEcCtD
Brinzolamide—Hypertension—Betamethasone—ankylosing spondylitis	0.00151	0.00154	CcSEcCtD
Brinzolamide—Hypertension—Dexamethasone—ankylosing spondylitis	0.00151	0.00154	CcSEcCtD
Brinzolamide—Myalgia—Betamethasone—ankylosing spondylitis	0.00149	0.00152	CcSEcCtD
Brinzolamide—Myalgia—Dexamethasone—ankylosing spondylitis	0.00149	0.00152	CcSEcCtD
Brinzolamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.00147	0.0015	CcSEcCtD
Brinzolamide—Discomfort—Betamethasone—ankylosing spondylitis	0.00147	0.0015	CcSEcCtD
Brinzolamide—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00146	0.0015	CcSEcCtD
Brinzolamide—Pain—Prednisolone—ankylosing spondylitis	0.00146	0.00149	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00145	0.00148	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00147	CcSEcCtD
Brinzolamide—Vision blurred—Prednisone—ankylosing spondylitis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00143	0.00146	CcSEcCtD
Brinzolamide—Insomnia—Triamcinolone—ankylosing spondylitis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00142	0.00145	CcSEcCtD
Brinzolamide—Infection—Betamethasone—ankylosing spondylitis	0.00141	0.00145	CcSEcCtD
Brinzolamide—Infection—Dexamethasone—ankylosing spondylitis	0.00141	0.00145	CcSEcCtD
Brinzolamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—ankylosing spondylitis	0.00141	0.00144	CcSEcCtD
Brinzolamide—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0014	0.00143	CcSEcCtD
Brinzolamide—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.0014	0.00143	CcSEcCtD
Brinzolamide—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.0014	0.00143	CcSEcCtD
Brinzolamide—Agitation—Prednisone—ankylosing spondylitis	0.0014	0.00143	CcSEcCtD
Brinzolamide—Tachycardia—Betamethasone—ankylosing spondylitis	0.00139	0.00142	CcSEcCtD
Brinzolamide—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00139	0.00142	CcSEcCtD
Brinzolamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00138	0.00141	CcSEcCtD
Brinzolamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00138	0.00141	CcSEcCtD
Brinzolamide—Malaise—Prednisone—ankylosing spondylitis	0.00137	0.0014	CcSEcCtD
Brinzolamide—Vertigo—Prednisone—ankylosing spondylitis	0.00137	0.00139	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—ankylosing spondylitis	0.00136	0.00139	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.00136	0.00139	CcSEcCtD
Brinzolamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00136	0.00139	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00135	0.00138	CcSEcCtD
Brinzolamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.00135	0.00138	CcSEcCtD
Brinzolamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00135	0.00138	CcSEcCtD
Brinzolamide—Pain—Triamcinolone—ankylosing spondylitis	0.00134	0.00137	CcSEcCtD
Brinzolamide—Hypotension—Dexamethasone—ankylosing spondylitis	0.00133	0.00136	CcSEcCtD
Brinzolamide—Hypotension—Betamethasone—ankylosing spondylitis	0.00133	0.00136	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—ankylosing spondylitis	0.00132	0.00135	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00132	0.00135	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00131	0.00134	CcSEcCtD
Brinzolamide—Hypertension—Prednisone—ankylosing spondylitis	0.00131	0.00134	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.0013	0.00133	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.0013	0.00133	CcSEcCtD
Brinzolamide—Myalgia—Prednisone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Arthralgia—Prednisone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Insomnia—Dexamethasone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Insomnia—Betamethasone—ankylosing spondylitis	0.00129	0.00132	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Discomfort—Prednisone—ankylosing spondylitis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—ankylosing spondylitis	0.00128	0.00131	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—ankylosing spondylitis	0.00127	0.0013	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—ankylosing spondylitis	0.00127	0.0013	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00126	0.00128	CcSEcCtD
Brinzolamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00125	0.00128	CcSEcCtD
Brinzolamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00125	0.00128	CcSEcCtD
Brinzolamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.00125	0.00127	CcSEcCtD
Brinzolamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00124	0.00127	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00124	0.00127	CcSEcCtD
Brinzolamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00124	0.00126	CcSEcCtD
Brinzolamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00124	0.00126	CcSEcCtD
Brinzolamide—Infection—Prednisone—ankylosing spondylitis	0.00123	0.00126	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00123	0.00126	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00123	0.00126	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—ankylosing spondylitis	0.00123	0.00126	CcSEcCtD
Brinzolamide—Fatigue—Betamethasone—ankylosing spondylitis	0.00123	0.00125	CcSEcCtD
Brinzolamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.00123	0.00125	CcSEcCtD
Brinzolamide—Pain—Dexamethasone—ankylosing spondylitis	0.00122	0.00124	CcSEcCtD
Brinzolamide—Pain—Betamethasone—ankylosing spondylitis	0.00122	0.00124	CcSEcCtD
Brinzolamide—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00122	0.00124	CcSEcCtD
Brinzolamide—Tachycardia—Prednisone—ankylosing spondylitis	0.00121	0.00124	CcSEcCtD
Brinzolamide—Skin disorder—Prednisone—ankylosing spondylitis	0.0012	0.00123	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—ankylosing spondylitis	0.0012	0.00122	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00118	0.0012	CcSEcCtD
Brinzolamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00117	0.0012	CcSEcCtD
Brinzolamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00117	0.0012	CcSEcCtD
Brinzolamide—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00116	0.00118	CcSEcCtD
Brinzolamide—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00115	0.00118	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—ankylosing spondylitis	0.00115	0.00117	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—ankylosing spondylitis	0.00114	0.00117	CcSEcCtD
Brinzolamide—Urticaria—Betamethasone—ankylosing spondylitis	0.00113	0.00116	CcSEcCtD
Brinzolamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.00113	0.00116	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00113	0.00115	CcSEcCtD
Brinzolamide—Dizziness—Prednisolone—ankylosing spondylitis	0.00113	0.00115	CcSEcCtD
Brinzolamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.00113	0.00115	CcSEcCtD
Brinzolamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00112	0.00115	CcSEcCtD
Brinzolamide—Insomnia—Prednisone—ankylosing spondylitis	0.00112	0.00115	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00111	0.00114	CcSEcCtD
Brinzolamide—Pruritus—Triamcinolone—ankylosing spondylitis	0.00111	0.00113	CcSEcCtD
Brinzolamide—Cough—Methotrexate—ankylosing spondylitis	0.00111	0.00113	CcSEcCtD
Brinzolamide—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00111	0.00113	CcSEcCtD
Brinzolamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.00109	0.00112	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—ankylosing spondylitis	0.00108	0.0011	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—ankylosing spondylitis	0.00108	0.0011	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—ankylosing spondylitis	0.00108	0.0011	CcSEcCtD
Brinzolamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.00108	0.0011	CcSEcCtD
Brinzolamide—Rash—Prednisolone—ankylosing spondylitis	0.00108	0.0011	CcSEcCtD
Brinzolamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.00107	0.0011	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00107	0.0011	CcSEcCtD
Brinzolamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Brinzolamide—Fatigue—Prednisone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Brinzolamide—Headache—Prednisolone—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—ankylosing spondylitis	0.00107	0.00109	CcSEcCtD
Brinzolamide—Dizziness—Triamcinolone—ankylosing spondylitis	0.00104	0.00106	CcSEcCtD
Brinzolamide—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00104	0.00106	CcSEcCtD
Brinzolamide—Infection—Methotrexate—ankylosing spondylitis	0.00103	0.00105	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Brinzolamide—Asthenia—Betamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Brinzolamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00104	CcSEcCtD
Brinzolamide—Nausea—Prednisolone—ankylosing spondylitis	0.00101	0.00104	CcSEcCtD
Brinzolamide—Pruritus—Dexamethasone—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Brinzolamide—Pruritus—Betamethasone—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—ankylosing spondylitis	0.00101	0.00103	CcSEcCtD
Brinzolamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000998	0.00102	CcSEcCtD
Brinzolamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000996	0.00102	CcSEcCtD
Brinzolamide—Rash—Triamcinolone—ankylosing spondylitis	0.000989	0.00101	CcSEcCtD
Brinzolamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000989	0.00101	CcSEcCtD
Brinzolamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000987	0.00101	CcSEcCtD
Brinzolamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000986	0.00101	CcSEcCtD
Brinzolamide—Urticaria—Prednisone—ankylosing spondylitis	0.000985	0.00101	CcSEcCtD
Brinzolamide—Headache—Triamcinolone—ankylosing spondylitis	0.000983	0.001	CcSEcCtD
Brinzolamide—Headache—Methylprednisolone—ankylosing spondylitis	0.000981	0.001	CcSEcCtD
Brinzolamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000974	0.000996	CcSEcCtD
Brinzolamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000974	0.000996	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—ankylosing spondylitis	0.000968	0.00099	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000944	0.000965	CcSEcCtD
Brinzolamide—Dizziness—Betamethasone—ankylosing spondylitis	0.000942	0.000962	CcSEcCtD
Brinzolamide—Dizziness—Dexamethasone—ankylosing spondylitis	0.000942	0.000962	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—ankylosing spondylitis	0.000937	0.000958	CcSEcCtD
Brinzolamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000932	0.000953	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000931	0.000951	CcSEcCtD
Brinzolamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.00093	0.00095	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000924	0.000944	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—ankylosing spondylitis	0.000921	0.000941	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000914	0.000934	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000912	0.000932	CcSEcCtD
Brinzolamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000905	0.000925	CcSEcCtD
Brinzolamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000905	0.000925	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000901	0.000921	CcSEcCtD
Brinzolamide—Rash—Dexamethasone—ankylosing spondylitis	0.000898	0.000917	CcSEcCtD
Brinzolamide—Rash—Betamethasone—ankylosing spondylitis	0.000898	0.000917	CcSEcCtD
Brinzolamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000897	0.000917	CcSEcCtD
Brinzolamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000897	0.000917	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000895	0.000914	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—ankylosing spondylitis	0.000894	0.000913	CcSEcCtD
Brinzolamide—Headache—Dexamethasone—ankylosing spondylitis	0.000892	0.000912	CcSEcCtD
Brinzolamide—Headache—Betamethasone—ankylosing spondylitis	0.000892	0.000912	CcSEcCtD
Brinzolamide—Asthenia—Prednisone—ankylosing spondylitis	0.00089	0.000909	CcSEcCtD
Brinzolamide—Pain—Methotrexate—ankylosing spondylitis	0.000886	0.000906	CcSEcCtD
Brinzolamide—Pruritus—Prednisone—ankylosing spondylitis	0.000877	0.000897	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000854	0.000873	CcSEcCtD
Brinzolamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000848	0.000867	CcSEcCtD
Brinzolamide—Nausea—Betamethasone—ankylosing spondylitis	0.000846	0.000864	CcSEcCtD
Brinzolamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000846	0.000864	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—ankylosing spondylitis	0.000823	0.000841	CcSEcCtD
Brinzolamide—Dizziness—Prednisone—ankylosing spondylitis	0.00082	0.000838	CcSEcCtD
Brinzolamide—Vomiting—Prednisone—ankylosing spondylitis	0.000788	0.000806	CcSEcCtD
Brinzolamide—Rash—Prednisone—ankylosing spondylitis	0.000782	0.000799	CcSEcCtD
Brinzolamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000781	0.000798	CcSEcCtD
Brinzolamide—Headache—Prednisone—ankylosing spondylitis	0.000777	0.000794	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000764	0.00078	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000744	0.00076	CcSEcCtD
Brinzolamide—Nausea—Prednisone—ankylosing spondylitis	0.000737	0.000753	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—ankylosing spondylitis	0.000733	0.000749	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000709	0.000725	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—ankylosing spondylitis	0.000685	0.0007	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000659	0.000673	CcSEcCtD
Brinzolamide—Rash—Methotrexate—ankylosing spondylitis	0.000653	0.000668	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000653	0.000667	CcSEcCtD
Brinzolamide—Headache—Methotrexate—ankylosing spondylitis	0.000649	0.000663	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—ankylosing spondylitis	0.000616	0.000629	CcSEcCtD
